Literature DB >> 25737670

Intra-articular Analgesia and Discharge to Home Enhance Recovery Following Total Knee Replacement.

Shivi Duggal1, Susan Flics1, Charles N Cornell2.   

Abstract

BACKGROUND: The increasing demand for total knee arthroplasty (TKR) and the initiatives to reduce health care spending have put the responsibility for efficient care on hospitals and providers. Multidisciplinary care pathways have been shown to shorten length of stay and result in improved short-term outcomes. However, common problems such as post-op nausea, orthostasis, and quad weakness remain, while reliance on discharge to rehabilitation facilities may also prolong hospital stay. QUESTIONS/PURPOSES: Our aim was to document that combined modifications of our traditional clinical pathway for unilateral TKR could lead to improved short-term outcomes. We pose the following research questions. Can pathway modifications which include intra-articular infusion and saphenous nerve block (SNB) provide adequate pain relief and eliminate common side effects promoting earlier mobilization? Can planning for discharge to home avoid in-patient rehab stays? Can these combined modifications decrease length of stay even in patients with complex comorbidities indicated by higher ASA class? Will discharge to home incur an increase in complications or a failure to achieve knee range of motion? PATIENTS AND METHODS: A retrospective review was performed and identified two cohorts. Group A included 116 patients that underwent unilateral TKR for osteoarthritis between August 2009 and August 2010. Group B included 171 patients that underwent unilateral TKR for osteoarthritis between February 2012 to February 2013. Group A patients were treated with spinal anesthesia with patient-controlled epidural analgesia (PCEA)/femoral nerve block (FNB) for the first 48 h after surgery. Discharge planning was initiated after admission. Group B had spinal anesthesia with SNB and received a continuous intra-articular infusion of 0.2% ropivicaine for 48 h post-op. Discharge planning was initiated with a case manager prior to hospitalization and discharge to home was declared the preferred approach. An intensive home PT program was made available through a program with our local home care agency. Outcomes assessed and compared between groups included length of stay, incidence of post-op nausea, dizziness, in-hospital falls, occurrence of complications including wound infection and the recovery of range of motion at 6 weeks, 3 months, and 1 year post-op.
RESULTS: Pain control was similar between the groups but Group B had fewer side effects. With the new pathway, length of stay (LOS) was reduced from 4.32 to 3.64 days with a similar LOS reduction across all ASA classes. There was no increase in Group B wound or other complications. Return of ROM was similar between groups.
CONCLUSIONS: Our findings suggest that replacing PCEA and FNB with intra-articular analgesia with a SNB allows for improved early recovery following TKR. That, combined with pre-op discharge planning and initiation of an intensive home PT program, reduced average length of stay.

Entities:  

Keywords:  TKR; clinical pathways; intra-articular analgesia

Year:  2014        PMID: 25737670      PMCID: PMC4342406          DOI: 10.1007/s11420-014-9414-8

Source DB:  PubMed          Journal:  HSS J        ISSN: 1556-3316


  22 in total

Review 1.  Effectiveness and practice variation of rehabilitation after joint replacement.

Authors:  Ewa M Roos
Journal:  Curr Opin Rheumatol       Date:  2003-03       Impact factor: 5.006

Review 2.  Epidural analgesia for pain relief following hip or knee replacement.

Authors:  P T Choi; M Bhandari; J Scott; J Douketis
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 3.  Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines.

Authors:  E S Krames
Journal:  J Pain Symptom Manage       Date:  1996-06       Impact factor: 3.612

4.  Increasing use of total knee replacement and revision surgery.

Authors:  James Slover; Joseph D Zuckerman
Journal:  JAMA       Date:  2012-09-26       Impact factor: 56.272

5.  A multimodal clinical pathway can reduce length of stay after total knee arthroplasty.

Authors:  Omri Ayalon; Spencer Liu; Susan Flics; Janet Cahill; Karen Juliano; Charles N Cornell
Journal:  HSS J       Date:  2010-05-22

6.  Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010.

Authors:  Peter Cram; Xin Lu; Stephen L Kates; Jasvinder A Singh; Yue Li; Brian R Wolf
Journal:  JAMA       Date:  2012-09-26       Impact factor: 56.272

7.  Femoral nerve block for total knee replacement - a word of caution.

Authors:  Mohanasundaram Kandasami; Andrew Wg Kinninmonth; Martin Sarungi; Joseph Baines; Nicholas B Scott
Journal:  Knee       Date:  2008-11-28       Impact factor: 2.199

8.  Comparison of home health care physical therapy outcomes following total knee replacement with and without subacute rehabilitation.

Authors:  Christopher E Chimenti; Gail Ingersoll
Journal:  J Geriatr Phys Ther       Date:  2007       Impact factor: 3.381

9.  Comparison of peri- and intraarticular analgesia with femoral nerve block after total knee arthroplasty: a randomized clinical trial.

Authors:  Karen Toftdahl; Lone Nikolajsen; Viggo Haraldsted; Frank Madsen; Else K Tønnesen; Kjeld Søballe
Journal:  Acta Orthop       Date:  2007-04       Impact factor: 3.717

10.  Postoperative analgesia in TKA: ropivacaine continuous intraarticular infusion.

Authors:  Primitivo Gómez-Cardero; E Carlos Rodríguez-Merchán
Journal:  Clin Orthop Relat Res       Date:  2010-05       Impact factor: 4.176

View more
  2 in total

1.  CORR Insights®: The 2018 Chitranjan S. Ranawat, MD Award: Developing and Implementing a Novel Institutional Guideline Strategy Reduced Postoperative Opioid Prescribing After TKA and THA.

Authors:  Shivi Duggal
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

Review 2.  Continuous Wound Infiltration of Local Anesthetics in Postoperative Pain Management: Safety, Efficacy and Current Perspectives.

Authors:  Giuseppe Paladini; Stefano Di Carlo; Giuseppe Musella; Emiliano Petrucci; Paolo Scimia; Andrea Ambrosoli; Vincenza Cofini; Pierfrancesco Fusco
Journal:  J Pain Res       Date:  2020-01-31       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.